Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | C159 - Stiff Person Syndrome Spectrum Disorder and Other Autoimmune Movement Disorders

Wednesday 04/17/24
01:00 PM - 03:00 PM MDT Add To Calendar
Colorado Convention Center | Bluebird 1A
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Scott Douglas Newsome, DO, FAAN
Autoimmune Neurology
Participants should become familiar with the expanding clinical spectrum of stiff person syndrome and other autoimmune movement disorders including identifying differing phenotypes. Additionally, participants should become familiar with the pertinent diagnostic work-up and treatment considerations for these diseases.
2.00 CME credits
Patient Care & Procedural Skills, Medical Knowledge
Introductory
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic, Other

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM MDT Introduction Welcome and Introductions
Scott Douglas Newsome, DO, FAAN
01:05 PM - 01:40 PM MDT Speaker Expanding Clinical Spectrum of Stiff Person Syndrome Spectrum Disorders
Scott Douglas Newsome, DO, FAAN
01:40 PM - 02:15 PM MDT Speaker Treatment Considerations in Stiff Person Syndrome Spectrum Disorders
Yujie Wang, MD
02:15 PM - 02:50 PM MDT Speaker Evolving Landscape of Autoimmune Movement Disorders
Bettina Balint, MD
02:50 PM - 03:00 PM MDT Q&A Questions & Answers
Scott Douglas Newsome, DO, FAAN, Bettina Balint, MD, Yujie Wang, MD
Faculty Disclosures
Scott Douglas Newsome, DO, FAAN Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Greenwich Biosciences. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics. Dr. Newsome has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. The institution of Dr. Newsome has received research support from Biogen. The institution of Dr. Newsome has received research support from Genentech/Roche. The institution of Dr. Newsome has received research support from Department of Defense. The institution of Dr. Newsome has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Newsome has received research support from National MS Society. The institution of Dr. Newsome has received research support from The Stiff Person Syndrome Research Foundation. The institution of Dr. Newsome has received research support from Lundbeck. Dr. Newsome has received personal compensation in the range of $10,000-$49,999 for serving as a Lead PI for Clinical Trial with Roche.
Bettina Balint, MD Dr. Balint has nothing to disclose.
Yujie Wang, MD Dr. Wang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Wang has received research support from Genentech.